Macropa-NH2 hydrochloride

Macropa-NCS is conjugated to Anti-Human HER2 as well as to the prostate-specific membrane antigen-targeting compound RPS-070 and is a promising therapeutic radionuclide applied in the treatment of soft-tissue metastases. Macropa-NH2 hydrochloride is the precursor of Macropa-NCS.